HUP0102036A2 - Orális hatóanyag szuszpenzió és eljárás az előállítására - Google Patents
Orális hatóanyag szuszpenzió és eljárás az előállításáraInfo
- Publication number
- HUP0102036A2 HUP0102036A2 HU0102036A HUP0102036A HUP0102036A2 HU P0102036 A2 HUP0102036 A2 HU P0102036A2 HU 0102036 A HU0102036 A HU 0102036A HU P0102036 A HUP0102036 A HU P0102036A HU P0102036 A2 HUP0102036 A2 HU P0102036A2
- Authority
- HU
- Hungary
- Prior art keywords
- suspension
- dispersion medium
- meloxicam
- nsaid
- small amount
- Prior art date
Links
- 239000000725 suspension Substances 0.000 title abstract 5
- 239000013543 active substance Substances 0.000 title abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 4
- 239000002612 dispersion medium Substances 0.000 abstract 3
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 2
- 229960001929 meloxicam Drugs 0.000 abstract 2
- 239000000377 silicon dioxide Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 229940100692 oral suspension Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
A találmány tárgya egy szuszpenzióképes részecskeméret-spektrummalrendelkező NSAID típusú gyógyszerhatóanyagnak, főleg a Meloxicamnakegy fiziológiailag közömbös olyan diszperziós közegben való orálisalkalmazású szuszpenziója, amelyben a hatóanyag oldhatósága nagyonkicsi, úgyhogy a szuszpenziónak nincs észrevehető saját íze, amit azjellemez, hogy a szuszpenzió egy háromdimenziós sziloid szerkezetkialakulásával a stabilizálás céljából kis mennyiségű nagyon diszperzszilícium-dioxidot tartalmaz, ahol a háromdimenziós sziloid szerkezeta szilícium-dioxidnak a diszperziós közegbe nagy nyíróerő behatásaközben való bevitelével keletkezik, és a szuszpenzió kis mennyiségbenmég a diszperziós közegben oldható hidrofil polimereket is tartalmaz.A találmány tárgya továbbá eljárás a szuszpenzió előállítására,valamint az NSAID típusú gyógyszerhatóanyagok, főleg a Meloxicamalkalmazása az ilyen szuszpenziók előállítására. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98105568A EP0945131A1 (de) | 1998-03-27 | 1998-03-27 | Perorale Wirkstoff-Suspension |
| PCT/EP1999/001948 WO1999049845A1 (de) | 1998-03-27 | 1999-03-23 | Perorale wirkstoff-suspension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0102036A2 true HUP0102036A2 (hu) | 2002-03-28 |
| HUP0102036A3 HUP0102036A3 (en) | 2002-12-28 |
| HU228474B1 HU228474B1 (en) | 2013-03-28 |
Family
ID=8231651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102036A HU228474B1 (en) | 1998-03-27 | 1999-03-23 | Peroral active agent suspension |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP0945131A1 (hu) |
| JP (1) | JP3323189B2 (hu) |
| KR (1) | KR100587208B1 (hu) |
| CN (1) | CN1150888C (hu) |
| AR (1) | AR016196A1 (hu) |
| AT (1) | ATE225648T1 (hu) |
| AU (1) | AU762464B2 (hu) |
| BR (1) | BR9909189A (hu) |
| CA (1) | CA2326048C (hu) |
| CO (1) | CO5070601A1 (hu) |
| DE (1) | DE59903023D1 (hu) |
| DK (1) | DK1066029T3 (hu) |
| ES (1) | ES2184428T3 (hu) |
| HK (1) | HK1034184A1 (hu) |
| HU (1) | HU228474B1 (hu) |
| IL (1) | IL137479A (hu) |
| MY (1) | MY124599A (hu) |
| NO (1) | NO321401B1 (hu) |
| NZ (1) | NZ507610A (hu) |
| PL (1) | PL192969B1 (hu) |
| PT (1) | PT1066029E (hu) |
| TR (1) | TR200002772T2 (hu) |
| TW (1) | TWI232759B (hu) |
| UY (1) | UY25443A1 (hu) |
| WO (1) | WO1999049845A1 (hu) |
| ZA (1) | ZA200003951B (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8231899B2 (en) | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
| US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| EP1938803A3 (en) * | 2003-03-03 | 2010-10-27 | Elan Pharma International Limited | Formulations comprising nanoparticulate meloxican |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| WO2004089427A1 (en) * | 2003-04-07 | 2004-10-21 | Jurox Pty Ltd | Stable carprofen composition |
| US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
| EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| WO2006042381A1 (en) * | 2004-10-21 | 2006-04-27 | Parnell Laboratories (Aust) Pty Limited | Anti-inflammatory preparation |
| DE602005009016D1 (de) | 2004-12-06 | 2008-09-25 | Janssen Pharmaceutica Nv | Orale suspension mit meloxicam |
| GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
| ES2981178T3 (es) | 2009-10-12 | 2024-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Recipientes para composiciones que comprenden meloxicam |
| MX2012010077A (es) | 2010-03-03 | 2012-09-12 | Boehringer Ingelheim Vetmed | Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos. |
| US20110218191A1 (en) * | 2010-03-03 | 2011-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long term-treatment of kidney disorders in cats |
| CA2800235C (en) * | 2010-03-10 | 2018-10-16 | Lupin Limited | Rifaximin ready-to-use suspension |
| DK3108750T3 (en) * | 2010-03-19 | 2018-10-22 | 1Globe Biomedical Co Ltd | NEW RELATIONS AND COMPOSITIONS TARGETED FOR CANCER STAM CELLS |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| GB201117858D0 (en) | 2011-10-17 | 2011-11-30 | Norbrook Lab Ltd | Paste |
| JP5908119B2 (ja) * | 2012-12-19 | 2016-04-26 | 三菱電機株式会社 | 空気調和機 |
| MX2017013715A (es) | 2015-04-28 | 2018-03-02 | Mars Inc | Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado. |
| KR102145022B1 (ko) * | 2018-08-14 | 2020-08-14 | 동아제약 주식회사 | 이부프로펜의 현탁액 조성물 및 투여 제형 |
| CN112044605B (zh) * | 2019-06-06 | 2022-06-21 | 钟志勇 | 选钛药剂及选钛方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196307B (it) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam monoidrato |
| US4835187A (en) * | 1987-06-15 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
| JP2860729B2 (ja) * | 1992-03-10 | 1999-02-24 | エスエス製薬株式会社 | プラノプロフェン懸濁シロップ剤 |
| GB2318511A (en) * | 1996-10-23 | 1998-04-29 | Eurand Int | Process for the preparation of a pharmaceutical composition for rapid suspension in water |
-
1998
- 1998-03-27 EP EP98105568A patent/EP0945131A1/de not_active Withdrawn
-
1999
- 1999-03-04 TW TW088103315A patent/TWI232759B/zh not_active IP Right Cessation
- 1999-03-23 JP JP2000540811A patent/JP3323189B2/ja not_active Expired - Lifetime
- 1999-03-23 EP EP99913291A patent/EP1066029B1/de not_active Expired - Lifetime
- 1999-03-23 CN CNB998044695A patent/CN1150888C/zh not_active Expired - Lifetime
- 1999-03-23 ES ES99913291T patent/ES2184428T3/es not_active Expired - Lifetime
- 1999-03-23 PL PL342345A patent/PL192969B1/pl unknown
- 1999-03-23 DE DE59903023T patent/DE59903023D1/de not_active Expired - Lifetime
- 1999-03-23 PT PT99913291T patent/PT1066029E/pt unknown
- 1999-03-23 HU HU0102036A patent/HU228474B1/hu unknown
- 1999-03-23 BR BR9909189-5A patent/BR9909189A/pt not_active Application Discontinuation
- 1999-03-23 TR TR2000/02772T patent/TR200002772T2/xx unknown
- 1999-03-23 DK DK99913291T patent/DK1066029T3/da active
- 1999-03-23 KR KR1020007010684A patent/KR100587208B1/ko not_active IP Right Cessation
- 1999-03-23 AU AU31470/99A patent/AU762464B2/en not_active Expired
- 1999-03-23 AT AT99913291T patent/ATE225648T1/de active
- 1999-03-23 CA CA002326048A patent/CA2326048C/en not_active Expired - Lifetime
- 1999-03-23 IL IL13747999A patent/IL137479A/xx not_active IP Right Cessation
- 1999-03-23 NZ NZ507610A patent/NZ507610A/en not_active IP Right Cessation
- 1999-03-23 WO PCT/EP1999/001948 patent/WO1999049845A1/de active IP Right Grant
- 1999-03-24 UY UY25443A patent/UY25443A1/es not_active IP Right Cessation
- 1999-03-25 MY MYPI99001139A patent/MY124599A/en unknown
- 1999-03-26 CO CO99018550A patent/CO5070601A1/es unknown
- 1999-03-26 AR ARP990101338A patent/AR016196A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
-
2000
- 2000-08-03 ZA ZA200003951A patent/ZA200003951B/xx unknown
- 2000-09-26 NO NO20004822A patent/NO321401B1/no not_active IP Right Cessation
-
2001
- 2001-07-04 HK HK01104589A patent/HK1034184A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102036A2 (hu) | Orális hatóanyag szuszpenzió és eljárás az előállítására | |
| Shu et al. | The release behavior of brilliant blue from calcium–alginate gel beads coated by chitosan: the preparation method effect | |
| TWI583387B (zh) | 包含官能化碳酸鈣之快速分解固體劑型調配物及其製備方法 | |
| TW200503779A (en) | Stable and taste masked pharmaceutical dosage form using porous apatite grains | |
| DE69727244D1 (de) | Hydrophile mikropartikel und verfahren zu deren herstellung | |
| WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
| AU5504599A (en) | Quick release pharmaceutical compositions of drug substances | |
| JPWO2007007659A1 (ja) | 錠剤 | |
| HUP0000141A2 (hu) | Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására | |
| ATE287704T1 (de) | Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür | |
| HUP0104653A2 (hu) | Nehezen oldódó kálciumsók finomrészecskés szuszpenziói és ezek felhasználása fogápoló szerekben | |
| TW201417843A (zh) | 含有酸性羧甲基纖維素及結晶纖維素之崩解性粒子組成物以及含有該組成物之口腔內崩解錠劑 | |
| HK1060691A1 (en) | Ion-strength independent sustained release pharmaceutical formulation | |
| EP1539146A1 (en) | Dispersible tablets for oral administration | |
| DE69937351D1 (de) | Partikelformende zubereitungen welche kondensierte pyrrolocarbazole enhalten | |
| IL152074A0 (en) | Pharmaceutical preparations and their manufacture | |
| BR9917220A (pt) | Composição para gomas de mascarmedicamentosas, processo para produção damesma, e tabletes assim obtidos | |
| JP4949826B2 (ja) | アモキシシリン三水和物結晶性粉末 | |
| MY147403A (en) | Composition containing medicine extremely slightly solube in water and method for preparation thereof | |
| CA2388325A1 (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| Sarkar et al. | Importance of wet packability of component particles in pellet formation | |
| EP2988727A1 (en) | Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof | |
| WO2003053403A3 (en) | Pharmaceutical suspension for oral administration | |
| HU219341B (en) | Process for producing pressed, moulded, delayed release dose units and dose units thus produced | |
| JP4336380B1 (ja) | 水懸濁性を向上させた細粒剤 |